Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07029932Phase 1Recruiting
Phase 1, randomised, double-blind trial in infectious disease comparing BWC0977 with Placebo (2 arms). Primary endpoint: Incidence of treatment-emergent adverse events and serious adverse events. Started Oct 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07029932.